Extend your OTC pharmaceutical product portfolio with a new delivery system to sooth and relieve sore throat
A two-year development successfully completed thanks to a strong strategic partnership that combines the chewing gum knowledge of Cafosa with the expertise in sore throat pharmaceutical developments of Geiser to deliver a unique, first to market product.
This product is used for local and temporary relief of the symptoms of mild buccopharyngeal infections, which are associated with pain and without fever such as: throat irritation, aphonia, small oral sores.
Download the file about Cough&Cold here
Why a medicated chewing gum?
- Chewing gum stimulates prolonged saliva production, which results in better throat hydration.
- Active ingredients remain longer in the mouth.
- The prolonged time in mouth while chewing favours API release.
- Efficient delivery, fast action: the API could be absorbed faster through the oral mucosa.
- Reduced exposure to gastrointestinal side effects.
- Convenient, discreet to administer, does not require water to swallow.
- May increase patient’s treatment compliance.
- Highly accepted by children.